BLOG

Thursday, July 29, 2021

Study tests microplasma against middle-ear infections

Middle-ear infections are a common affliction in early life, affecting more than 80% of children in the U.S. Antibiotics are often employed as a first line of defense but sometimes fail against the pathogenic bacteria that can develop in the middle ear, just behind the eardrum. In a new study, researchers explore the use of microplasma -- a highly focused stream of chemically excited ions and molecules -- as a noninvasive method for attacking the bacterial biofilms that resist antibiotic treatment in the middle ear.

from Top Health News -- ScienceDaily https://ift.tt/3BYnY5R

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...